Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibody Drug Conjugates

Antibody Drug Conjugates Agenda



Co-Located Conference Agendas

Biomarkers - From Research To Commercialization | Antibody Drug Conjugates | 

Print Agenda

Thursday, 24 May 2018

08:00

Registration


Inauguration

09:00

Welcome Address

09:05

Speakers' Introduction & Memento Presentation

09:25

Card Exchange and Networking Session

09:40

Coffee Break and Networking in Exhibition Area


Scientific Session I - Antibody Engineering

10:10

Yesterday, Today and Tomorrow of Antibody
Manjula Das, Principal Investigator, Mazumdar Shaw Center for Translational Research (MSCTR), India

10:45

Q/A Discussion

10:50

Rajan DigheKeynote Presentation

Cancer Immunotherapeutics: Combining the Basic and Translational Research
Rajan Dighe, Professor, Indian Institute of Science, India

11:30

Q/A Discussion

11:35

Antibody Engineering in Biotherapeutic Development
Ashvini Kumar Dubey, Senior Scientist, Zumutor Biologics, India

12:10

Q/A Discussion

12:15

AbTids - A New Class of Antimicrobials
Sanjiban K Banerjee, Director, AbGenics Lifesciences Pvt Ltd, India

12:50

Q/A Discussion

12:55

Antibody Engineering Approach for High Quality Clone & Process Development
Shailja Dwivedi, Sr. Research Executive- Advanced Biotech Lab, Ipca Laboratories Ltd, India

13:30

Q/A Discussion

13:35

Group Photograph Session

13:45

Lunch Break and Networking in Exhibition Area


Scientific Session II - ADC Development

14:45

Development of Site-Specific Steroid-ADC for the Treatment of Inflammatory Diseases
Amy Han, Director, Chemistry, Regeneron Pharmaceuticals, United States of America

15:20

Q/A Discussion

15:25

Next Generation Antibody Drug Conjugates (ADCs): Firing Magical Bullets Continues
Syeda Warisul Fatima, Research Scholar, Indian Institute of Technology Delhi, India

15:35

Q/A Discussion

15:40

Coffee Break and Networking in Exhibition Area

16:10

Dimiter Stanchev DimitrovKeynote Presentation

Dual Targeting Antibody-Drug Conjugates (ADCs) – Tumors and Their Vasculature
Dimiter Stanchev Dimitrov, Professor, University of Pittsburgh, United States of America

16:50

Q/A Discussion

16:55

Conference Feedback

17:00

End of First Day of Conference

Friday, 25 May 2018


Technical Session

09:01

Introduction to Technical Session

09:10

KRISHGEN BiosystemsDeveloping Validated Assays for Biomarkers and Antibody Drug Conjugates
Kalpesh Jain, Founder and Technical Head, KRISHGEN Biosystems

09:35

Q/A Discussion

09:40

Agilent Technologies India Pvt Ltd.Technology Spotlight:
Glimpses of Solutions and Portfolio for Advanced Applications
Ashish Pargaonkar, Field Applications Specialist - Biopharma, Agilent Technologies India Pvt Ltd.

09:55

SartoriusTechnology Spotlight:
iQue® Plus - Unique Among Flow-Cytometers
Suyog Jakhadi, Product Manager- Bio-Analytics & Liquid Handling Products, Sartorius

10:10

GeNext Genomics Pvt LtdTechnology Spotlight:
Antibody Engineering reducing Antibody Dilemma in Biomarkers Study
Rashmi Upadhyay, Head- Sales & Marketing, GeNext Genomics Pvt Ltd

10:25

Coffee Break and Networking in Exhibition Area


Scientific Session III - ADC Analysis

10:55

Syngene International LtdSteps in Designing an ADC
Priyaranjan Pattanaik, Associate Research Director, Syngene International Ltd

11:30

Q/A Discussion

11:35

A Streamlined Drug-to-Antibody Ratio Determination Workflow for Intact and Deglycosylated Antibody-Drug Conjugates
Ashish Pargaonkar, Field Applications Specialist - Biopharma, Agilent Technologies India Pvt Ltd., India

12:10

Q/A Discussion

12:15

Interactive Session
This is going to be a special designed interactive session wherein, the delegates will get an excellent opportunity to interact with the renowned experts/speakers in an informal open discussion giving them a chance to put up queries and get solutions.

12:55

Lunch Break and Networking in Exhibition Area


Scientific Session IV - Overcoming Challenges in Development of Successful ADCs

13:55

Nitin DamleKeynote Presentation

Antibody-Drug Conjugates: Challenges in Translating Preclinical Success into Clinical Reality in Cancer Therapy Immunotherapy
Nitin Damle, Senior Vice President and Head, Discovery Biology/ CSO, Sun Pharma Advanced Research Company Limited, India

14:35

Q/A Discussion

14:40

The Curious Case of T-DM1 – First Antibody Drug Conjugate for HER2 Positive Breast Cancer
Jagdish Nigade, Group Medical Manager, Roche, India

15:15

Q/A Discussion

15:20

Coffee Break and Networking in Exhibition Area

15:50

Satish SinghKeynote Presentation

Antibody Drug Conjugates: Understanding the Intricacies of Design, Formulation and Product Manufacturing
Satish Singh, Head, Lonza Inc, Switzerland

16:30

Q/A Discussion

16:35

Conference Feedback

16:40

Closing Remarks and Vote of Thanks

16:45

End of Conference


Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonAntibody Drug ConjugatesAntibody Drug Conjugates in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com